Webinars

Are you developing an in vivo small animal bioluminescent imaging (BLI) model? Are you interested in the latest tools and techniques that expand the capabilities of traditional BLI? In vivo bioluminescent imaging is a non-invasive method to monitor biological events in living animals, enabling the study of dynamic processes in real-time within a complex biological system. Before investing time and resources in developing an in vivo BLI model, it is important to ensure you have optimized the design to meet your experimental goals. Join our featured experts from Promega and Spectral Instruments Imaging where they will walk through the three basic elements of any in vivo BLI experiment: the bioluminescent reporter protein, the reporter substrate, and the instrument you will use to measure the bioluminescent signal. They will also discuss key considerations for each of these elements and provide application examples, such as in vivo CAR-T cell tracking, that demonstrate how different experimental goals can influence your model design.

Are you interested in assessing the function or viability of PBMCs in-vitro? Do you want to know if extended culture influences PBMC viability and/or cytotoxicity? Peripheral blood mononuclear cells (PBMCs) are one of the most widely used models in biomedical research. However, the stability of PBMCs in culture post isolation is not well documented. Typically, PBMC viability or cytotoxicity is measured at a single time point after isolation, providing a limited snapshot of PBMC health for assays that last over multiple days. In this webinar you will learn how to multiplex cellular health assays to establish real-time effects of in-vitro culture on PBMC viability and cytotoxicity.

Routine testing for wastewater disease surveillance has expanded to screen for additional targets including the identification of emerging pathogens, seasonal respiratory diseases, such as influenza, and even antimicrobial resistance genes. Join us for a webinar featuring Senior Scientist Subhanjan Mondal discussing updated Promega methods for streamlining wastewater disease surveillance. He will also discuss how improved wastewater workflows propel the public health space and environmental testing field closer toward a OneHealth vision.